This Dental Equipment Maker Has Visible EPS Growth Despite A Challenging Macro: Analyst
Portfolio Pulse from Vandana Singh
Needham initiated coverage on Dentsply Sirona Inc (NASDAQ:XRAY) with a Buy rating and a price target of $35, citing the company's potential for 4-6% organic growth and margin expansion by 2026. Despite macroeconomic challenges, Needham expects double-digit EPS growth for XRAY in the coming years. The firm notes that XRAY's shares are attractively valued at a P/E multiple of 16.0x, in line with peers, and are currently trading up 0.63% at $29.50.
November 16, 2023 | 5:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham's initiation of coverage on Dentsply Sirona with a Buy rating and a $35 price target suggests confidence in the company's growth strategy and potential for margin expansion, which could positively influence investor sentiment and the stock price in the short term.
The initiation of coverage by Needham with a positive outlook is likely to instill confidence in investors, potentially leading to an increase in the stock price. The specific mention of expected EPS growth and a set price target provides a clear positive signal to the market. The current trading up of 0.63% also indicates a positive short-term reaction to the news.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100